Main > ONCOLOGY (**) > Leukemia>Myeloid>Chronic>Ph+ * > Treatment > Co.: CH. N. Brand Nilotinib > Companion Diagnostic.>

---

for Chronic Myeloid Leukemia (CML) patients in the chronic phase (CP) being treated with nilotinib who may be candidates for treatment discontinuation and monitoring of treatment-free remission (TFR).

Companion Diagnostic.>'s subsections
>(*) USA Launch Date: 2018. 09.04.
>Company
>TradeMark
>TradeMark Web-Site

Companion Diagnostic.>'s products
This section has no products